An update on the ability of St. John's wort to affect the metabolism of other drugs

Bibliography

• Rahimi R, Nikfar S, Abdollahi M. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:118-27
   PubMed Web of Science ®Google Scholar
• Husain GM, Chatterjee SS, Singh PN, Kumar V. Hypolipidemic and antiobesity-like activity of standardised extract of Hypericum perforatum L. in rats. ISRN Pharmacol 2011;2011:505247
   PubMedGoogle Scholar
• Mozaffari S, Esmaily H, Rahimi R, Effects of Hypericum perforatum extract on rat irritable bowel syndrome. Pharm Mag 2011;7:213-23
   PubMed Web of Science ®Google Scholar
• Dost T, Ozkayran H, Gokalp F, The effect of Hypericum perforatum (St. John's Wort) on experimental colitis in rat. Dig Dis Sci 2009;54:1214-21
   PubMed Web of Science ®Google Scholar
• Saddiqe Z, Naeem I, Maimoona A. A review of the antibacterial activity of Hypericum perforatum L. J Ethnopharmacol 2010;131:511-21
   PubMed Web of Science ®Google Scholar
• Birt DF, Widrlechner MP, Hammer KD, Hypericum in infection: identification of anti-viral and anti-inflammatory constituents. Pharm Biol 2009;47:774-82
   PubMed Web of Science ®Google Scholar
• Dikmen M, Ozturk Y, Sagratini G, Evaluation of the wound healing potentials of two subspecies of Hypericum perforatum on cultured NIH3T3 fibroblasts. Phytother Res 2011;25:208-14
   PubMed Web of Science ®Google Scholar
• Galeotti N, Vivoli E, Bilia AR, A prolonged protein kinase C-mediated, opioid-related antinociceptive effect of St John's wort in mice. J Pain 2010;11:149-59
   PubMed Web of Science ®Google Scholar
• Kumar V, Singh PN, Muruganandam AV, Bhattacharya SK. Effect of Indian Hypericum perforatum Linn on animal models of cognitive dysfunction. J Ethnopharmacol 2000;72:119-28
   PubMed Web of Science ®Google Scholar
• Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician 2007;76:391-6
   PubMed Web of Science ®Google Scholar
• Lewis DF. 57 varieties: the human cytochromes P450. Pharmacogenomics 2004;5:305-18
   PubMed Web of Science ®Google Scholar
• Markowitz JS, Donovan JL, DeVane CL, Effect of HP on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003;290:1500-4
   PubMed Web of Science ®Google Scholar
• Wang Z, Gorski JC, Hamman MA, The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 2001;70:317-26
   PubMed Web of Science ®Google Scholar
• Wenk M, Todesco L, Krahenbuhl S. Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females. Br J Clin Pharmacol 2004;57:495-9
   PubMed Web of Science ®Google Scholar
• Shibayama Y, Ikeda R, Motoya T, Yamada K. St. John's wort (Hypericum perforatum) induces overexpression of multidrug resistance protein 2 (MRP2) in rats: a 30-day ingestion study. Food Chem Toxicol 2004;42:995-1002
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Gardner SF, Hubbard MA, Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: st John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005;22:525-39
   PubMed Web of Science ®Google Scholar
• Bray BJ, Perry NB, Menkes DB, Rosengren RJ. St. John's wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse. Toxicol Sci 2002;66:27-33
   PubMed Web of Science ®Google Scholar
• Dostalek M, Pistovcakova J, Jurica J, Effect of St John's wort (Hypericum perforatum) on cytochrome P-450 activity in perfused rat liver. Life Sci 2005;78:239-44
   PubMed Web of Science ®Google Scholar
• Wang LS, Zhu B, Abd El-Aty AM, The influence of St John's wort on CYP2C19 activity with respect to genotype. J Clin Pharmacol 2004;44:577-81
   PubMed Web of Science ®Google Scholar
• Cantoni L, Rozio M, Mangolini A, Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse. Toxicol Sci 2003;75:25-30
   PubMed Web of Science ®Google Scholar
• Mueller SC, Majcher-Peszynska J, Mundkowski RG, No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers. Eur J Clin Pharmacol 2009;65:81-7
   PubMed Web of Science ®Google Scholar
• Mueller SC, Majcher-Peszynska J, Uehleke B, The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol 2006;62:29-36
   PubMed Web of Science ®Google Scholar
• Moore LB, Goodwin B, Jones SA, St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 2000;97:7500-2
   PubMed Web of Science ®Google Scholar
• di Masi A, De Marinis E, Ascenzi P, Marino M. Nuclear receptors CAR and. PXR: molecular, functional, and biomedical aspects. Mol Aspects Med 2009;30:297-343
   PubMed Web of Science ®Google Scholar
• Willson TM, Kliewer SA. PXR, CAR and drug metabolism. Nat Rev Drug Discov 2002;1:259-66
   PubMed Web of Science ®Google Scholar
• Kober M, Pohl K, Efferth T. Molecular mechanisms underlying St. John's wort drug interactions. Curr Drug Metab 2008;9:1027-37
   PubMed Web of Science ®Google Scholar
• Godtel-Armbrust U, Metzger A, Kroll U, Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort. Naunyn Schmiedebergs Arch Pharmacol 2007;375:377-82
   PubMed Web of Science ®Google Scholar
• Vlachojannis J, Cameron M, Chrubasik S. Drug interactions with St. John's wort products. Pharmacol Res 2010;62:207-27
   PubMedGoogle Scholar
• Arold G, Donath F, Maurer A, No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract. Planta Med 2005;71:331-7
   PubMed Web of Science ®Google Scholar
• Komoroski BJ, Zhang S, Cai H, Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metab Dispos 2004;32:512-18
   PubMed Web of Science ®Google Scholar
• Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther 2000;294:88-95
   PubMed Web of Science ®Google Scholar
• Lee JY, Duke RK, Tran VH, Hyperforin and its analogues inhibit CYP3A4 enzyme activity. Phytochemistry 2006;67:2550-60
   PubMed Web of Science ®Google Scholar
• Bray BJ, Brennan NJ, Perry NB, Short term treatment with St. John's wort, hypericin or hyperforin fails to induce CYP450 isoforms in the Swiss Webster mouse. Life Sci 2002;70:1325-35
   PubMed Web of Science ®Google Scholar
• Noldner M, Chatterjee S. Effects of two different extracts of St. John's wort and some of their constituents on cytochrome P450 activities in rat liver microsomes. Pharmacopsychiatry 2001;34:S108-10
   Google Scholar
• Hennessy M, Kelleher D, Spiers JP, St Johns wort increases expression of P-glycoprotein: implications for drug interactions. Br J Clin Pharmacol 2002;53:75-82
   PubMed Web of Science ®Google Scholar
• Lin JH, Yamazaki M. Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet 2003;42:59-98
   PubMed Web of Science ®Google Scholar
• Durr D, Stieger B, Kullak-Ublick GA, St John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 2000;68:598-604
   PubMed Web of Science ®Google Scholar
• Perloff MD, von Moltke LL, Stormer E, Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol 2001;134:1601-8
   PubMed Web of Science ®Google Scholar
• Wang EJ, Barecki-Roach M, Johnson WW. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin. J Pharm Pharmacol 2004;56:123-8
   PubMed Web of Science ®Google Scholar
• Dasgupta A, Hovanetz M, Olsen M, Drug-herb interaction: effect of St John's wort on bioavailability and metabolism of procainamide in mice. Arch Pathol Lab Med 2007;131:1094-8
   PubMed Web of Science ®Google Scholar
• Mueller SC, Uehleke B, Woehling H, Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin. Clin Pharmacol Ther 2004;75:546-57
   PubMed Web of Science ®Google Scholar
• Johne A, Schmider J, Brockmoller J, Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort (Hypericum perforatum). J Clin Psychopharmacol 2002;22:46-54
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan K, Greenblatt DJ, von Moltke LL, Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4. J Clin Pharmacol 1998;38:112-21
   PubMed Web of Science ®Google Scholar
• Uhr M, Steckler T, Yassouridis A, Holsboer F. Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a p-glycoprotein gene disruption. Neuropsychopharmacology 2000;22:380-7
   PubMed Web of Science ®Google Scholar
• Lei HP, Yu XY, Xie HT, Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers. Xenobiotica 2010;40:275-81
   PubMed Web of Science ®Google Scholar
• Turkanovic J, Ngo SN, Milne RW. Effect of St John's wort on the disposition of fexofenadine in the isolated perfused rat liver. J Pharm Pharmacol 2009;61:1037-42
   PubMed Web of Science ®Google Scholar
• Burstein AH, Horton RL, Dunn T, Lack of effect of St John's wort on carbamazepine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 2000;68:605-12
   PubMed Web of Science ®Google Scholar
• Mathijssen RH, Verweij J, de Bruijn P, Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 2002;94:1247-9
   PubMed Web of Science ®Google Scholar
• Hu ZP, Yang XX, Chen X, A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort. Curr Drug Metab 2007;8:157-71
   PubMed Web of Science ®Google Scholar
• Hu ZP, Yang XX, Chan SY, St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis. Toxicol Appl Pharmacol 2006;216:225-37
   PubMed Web of Science ®Google Scholar
• Hu Z, Yang X, Ho PC, St. John's wort modulates the toxicities and pharmacokinetics of CPT-11 (irinotecan) in rats. Pharm Res 2005;22:902-14
   PubMed Web of Science ®Google Scholar
• Kim SJ, Um JY, Lee JY. Anti-inflammatory activity of hyperoside through the suppression of nuclear factor-kappaB activation in mouse peritoneal macrophages. Am J Chin Med 2011;39:171-81
   PubMed Web of Science ®Google Scholar
• Zdunic G, Godevac D, Milenkovic M, Evaluation of Hypericum perforatum oil extracts for an antiinflammatory and gastroprotective activity in rats. Phytother Res 2009;23:1559-64
   PubMed Web of Science ®Google Scholar
• Komoroski BJ, Parise RA, Egorin MJ, Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures. Clin Cancer Res 2005;11:6972-9
   PubMed Web of Science ®Google Scholar
• Smith PF, Bullock JM, Booker BM, Induction of imatinib metabolism by hypericum perforatum. Blood 2004;104:1229-30
   PubMed Web of Science ®Google Scholar
• Frye RF, Fitzgerald SM, Lagattuta TF, Effect of St John's wort on imatinib mesylate pharmacokinetics. Clin Pharmacol Ther 2004;76:323-9
   PubMed Web of Science ®Google Scholar
• Berka K, Hendrychova T, Anzenbacher P, Otyepka M. Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site. J Phys Chem A 2011;115:11248-55
   PubMed Web of Science ®Google Scholar
• Bell EC, Ravis WR, Lloyd KB, Stokes TJ. Effects of St. John's wort supplementation on ibuprofen pharmacokinetics. Ann Pharmacother 2007;41:229-34
   PubMed Web of Science ®Google Scholar
• Johne A, Brockmoller J, Bauer S, Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999;66:338-45
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Swain A, Williams DK, Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics. Mol Nutr Food Res 2008;52:772-9
   PubMed Web of Science ®Google Scholar
• Portoles A, Terleira A, Calvo A, Effects of Hypericum perforatum on ivabradine pharmacokinetics in healthy volunteers: an open-label, pharmacokinetic interaction clinical trial. J Clin Pharmacol 2006;46:1188-94
   PubMed Web of Science ®Google Scholar
• Schwarz UI, Hanso H, Oertel R, Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol. Clin Pharmacol Ther 2007;81:669-78
   PubMed Web of Science ®Google Scholar
• Tannergren C, Engman H, Knutson L, St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism. Clin Pharmacol Ther 2004;75:298-309
   PubMed Web of Science ®Google Scholar
• Bell EC, Ravis WR, Chan HM, Lin YJ. Lack of pharmacokinetic interaction between St. John's wort and prednisone. Ann Pharmacother 2007;41:1819-24
   PubMed Web of Science ®Google Scholar
• Donovan JL, DeVane CL, Lewis JG, Effects of St John's wort (Hypericum perforatum L.) extract on plasma androgen concentrations in healthy men and women: a pilot study. Phytother Res 2005;19:901-6
   PubMed Web of Science ®Google Scholar
• Lau WC, Welch TD, Shields T, The effect of St John's wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity. J Cardiovasc Pharmacol 2011;57:86-93
   PubMed Web of Science ®Google Scholar
• Lau WC, Gurbel PA, Watkins PB, Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation 2004;109:166-71
   PubMed Web of Science ®Google Scholar
• Jiang X, Blair EY, McLachlan AJ. Investigation of the effects of herbal medicines on warfarin response in healthy subjects: a population pharmacokinetic-pharmacodynamic modeling approach. J Clin Pharmacol 2006;46:1370-8
   PubMed Web of Science ®Google Scholar
• Jiang X, Williams KM, Liauw WS, Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2004;57:592-9
   PubMed Web of Science ®Google Scholar
• Groning R, Breitkreutz J, Muller RS. Physico-chemical interactions between extracts of Hypericum perforatum L. and drugs. Eur J Pharm Biopharm 2003;56:231-6
   PubMed Web of Science ®Google Scholar
• Andren L, Andreasson A, Eggertsen R. Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia. Eur J Clin Pharmacol 2007;63:913-16
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Ohmori M, Tsuruoka S, Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 2001;70:518-24
   PubMed Web of Science ®Google Scholar
• Neuvonen PJ, Backman JT, Niemi M. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin. Clin Pharmacokinet 2008;47:463-74
   PubMed Web of Science ®Google Scholar
• Gordon RY, Becker DJ, Rader DJ. Reduced efficacy of rosuvastatin by St. John's Wort. Am J Med 2009;122:e1-2
   PubMed Web of Science ®Google Scholar
• Eggertsen R, Andreasson A, Andren L. Effects of treatment with a commercially available St John's wort product (Movina) on cholesterol levels in patients with hypercholesterolemia treated with simvastatin. Scand J Prim Health Care 2007;25:154-9
   PubMed Web of Science ®Google Scholar
• Van Strater AC, Bogers JP. Interaction of St John's wort (Hypericum perforatum) with clozapine. Int Clin Psychopharmacol 2012;27:121-4
   PubMed Web of Science ®Google Scholar
• Lundahl A, Hedeland M, Bondesson U, The effect of St. John's wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men. Eur J Pharm Sci 2009;36:433-43
   PubMed Web of Science ®Google Scholar
• Huskey SW, Dean DC, Miller RR, Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride. Drug Metab Dispos 1995;23:1126-35
   PubMed Web of Science ®Google Scholar
• Xu H, Williams KM, Liauw WS, Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. Br J Pharmacol 2008;153:1579-86
   PubMed Web of Science ®Google Scholar
• Ho YF, Huang DK, Hsueh WC, Effects of St. John's wort extract on indinavir pharmacokinetics in rats: differentiation of intestinal and hepatic impacts. Life Sci 2009;85:296-302
   PubMed Web of Science ®Google Scholar
• Wang LS, Zhou G, Zhu B, St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clin Pharmacol Ther 2004;75:191-7
   PubMed Web of Science ®Google Scholar
• Morimoto T, Kotegawa T, Tsutsumi K, Effect of St. John's wort on the pharmacokinetics of theophylline in healthy volunteers. J Clin Pharmacol 2004;44:95-101
   PubMed Web of Science ®Google Scholar
• Bauer S, Stormer E, Johne A, Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients. Br J Clin Pharmacol 2003;55:203-11
   PubMed Web of Science ®Google Scholar
• Moschella C, Jaber BL. Interaction between cyclosporine and Hypericum perforatum (St. John's wort) after organ transplantation. Am J Kidney Dis 2001;38:1105-7
   PubMed Web of Science ®Google Scholar
• Mai I, Kruger H, Budde K, Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin. Int J Clin Pharmacol Ther 2000;38:500-2
   PubMed Web of Science ®Google Scholar
• Turton-Weeks SM, Barone GW, Gurley BJ, St John's wort: a hidden risk for transplant patients. Prog Transplant 2001;11:116-20
   PubMedGoogle Scholar
• Ruschitzka F, Meier PJ, Turina M, Acute heart transplant rejection due to Saint John's wort. Lancet 2000;355:548-9
   PubMed Web of Science ®Google Scholar
• Barone GW, Gurley BJ, Ketel BL, Drug interaction between St. John's wort and cyclosporine. Ann Pharmacother 2000;34:1013-16
   PubMed Web of Science ®Google Scholar
• Karliova M, Treichel U, Malago M, Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol 2000;33:853-5
   PubMed Web of Science ®Google Scholar
• Mai I, Bauer S, Perloff ES, Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction. Clin Pharmacol Ther 2004;76:330-40
   PubMed Web of Science ®Google Scholar
• Mai I, Stormer E, Bauer S, Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients. Nephrol Dial Transplant 2003;18:819-22
   PubMed Web of Science ®Google Scholar
• Hebert MF, Park JM, Chen YL, Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol 2004;44:89-94
   PubMed Web of Science ®Google Scholar
• Pfrunder A, Schiesser M, Gerber S, Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial. Br J Clin Pharmacol 2003;56:683-90
   PubMed Web of Science ®Google Scholar
• Hall SD, Wang Z, Huang SM, The interaction between St John's wort and an oral contraceptive. Clin Pharmacol Ther 2003;74:525-35
   PubMed Web of Science ®Google Scholar
• Murphy PA, Kern SE, Stanczyk FZ, Westhoff CL. Interaction of St. John's wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception 2005;71:402-8
   PubMed Web of Science ®Google Scholar
• Will-Shahab L, Bauer S, Kunter U, St John's wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive. Eur J Clin Pharmacol 2009;65(3):287-94; Epub 2008 Nov 18. Erratum in: Eur J Clin Pharmacol 2009;65:541
   PubMed Web of Science ®Google Scholar
• Fogle RH, Murphy PA, Westhoff CL, Stanczyk FZ. Does St. John's wort interfere with the antiandrogenic effect of oral contraceptive pills? Contraception 2006;74(3):245-8
   PubMed Web of Science ®Google Scholar
• Qi JW, Nakamura K, Hosokawa S, Time-dependent induction of midazolam-1-hydroxylation enzymes in rats treated with St. John's wort. Biol Pharm Bull 2005;28:1467-71
   PubMed Web of Science ®Google Scholar
• Kawaguchi A, Ohmori M, Tsuruoka S, Drug interaction between St John's wort and quazepam. Br J Clin Pharmacol 2004;58:403-10
   PubMed Web of Science ®Google Scholar
• Hojo Y, Echizenya M, Ohkubo T, Shimizu T. Drug interaction between St John's wort and zolpidem in healthy subjects. J Clin Pharm Ther 2011;36:711-15
   PubMed Web of Science ®Google Scholar